
zzso zzso zzso and zzso zzso zzso are selective zzso zzso zzso that have proven very effective in the prevention of vomiting and zzso in adults and children receiving cancer zzso This study compared the efficacy of the two agents in the prevention of vomiting and zzso in children receiving chemotherapy for solid tumors and blood zzso A total of 23 children were studied in 205 zzso cycles zzso one-day regimens and 89 zzso zzso In 102 zzso cycles the children received zzso as an zzso agent in a dose of 5 zzso 30 zzso before chemotherapy was given and then 4 zzso every 8 h zzso zzso zzso and in 103 cycles they received zzso in one dose of zzso zzso 24 zzso zzso zzso dose 5 zzso 30 zzso before zzso drugs administration every day they received chemotherapy zzso zzso The response was defined as complete in the absence of zzso and vomiting per 24 h of chemotherapy, as partial given the presence of zzso events of vomiting and/or zzso less than 5 h per 24 zzso and as failure if there were more than 4 events of vomiting and/or zzso for more than 5 h per 24 h of zzso The response of the two groups was studied independently and depending on the degree of zzso of the zzso agents, which were divided into zzso zzso and highly zzso The comparison of the two groups not taking into consideration the zzso of the zzso agents showed that zzso was more effective in zzso regimens zzso zzso zzso whereas the two agents were equally effective in zzso regimens zzso zzso zzso The statistical analysis depending on the zzso of the zzso agents showed increased efficacy of zzso in mild zzso zzso zzso and moderately zzso zzso agents, whereas there was no difference in the highly zzso drug zzso zzso is found to be more effective than zzso in controlling acute zzso and vomiting in children receiving mild and moderately zzso zzso drugs, although there is no difference in the efficacy of both zzso agents when highly zzso drugs are zzso 

